Heartbeam, Inc. Common Stock
BEAT Real Time Price USDRecent trades of BEAT by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by BEAT's directors and management
Government lobbying spending instances
-
$10,000 May 31, 2023 Issue: Medicare/Medicaid
-
$40,000 May 31, 2023 Issue: Medicare/Medicaid
-
$20,000 May 31, 2023 Issue: Medicare/Medicaid
-
$130,000 May 31, 2023 Issue: Medicare/Medicaid
-
$20,000 Oct 18, 2022 Issue: Medicare/Medicaid
-
$130,000 Jul 12, 2022 Issue: Medicare/Medicaid
-
$10,000 Jan 18, 2022 Issue: Medicare/Medicaid
-
$10,000 Jan 18, 2021 Issue: Health Issues
-
$10,000 Oct 18, 2020 Issue: Health Issues
-
$10,000 Jul 20, 2020 Issue: Health Issues
-
$20,000 Jul 17, 2020 Issue: Medicare/Medicaid
-
$20,000 Apr 20, 2020 Issue: Medicare/Medicaid
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of BEAT in WallStreetBets Daily Discussion
Recent insights relating to BEAT
Recent picks made for BEAT stock on CNBC
ETFs with the largest estimated holdings in BEAT
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view BEAT Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.